eli lilly gip/glp-1 GLP4 coming out will release animal study data for at QUINTUPLE AGONIST at #ADA2026 For reference: Semaglutide= GLP1 Tirzepatide = GLP1/GIP Retatrutide = GLP1/GIP/Glucagon New Mol = GLP1/GIP/Glucagon/Amylin/Calcitonin Early rat Eli Lilly stock soars on

Contact us today to explore your best options for metabolic support and advanced weight loss

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinsons disease occurring with type 2 diabetes in a Taiwanese population cohort

Another study worth considering is the 2020 study that found over 140 adverse vision effects from the use of semaglutide, the active ingredient in Ozempic

Standing for glucagon-like peptide-1, GLP-1 is a naturally occurring hormone that plays a key role in regulating blood sugar levels, appetite, and even the bodys ability to metabolise fat

Obesity is linked to leading causes of death, including heart disease and diabetes

Understanding variants in GLP1R, GIPR, FTO, and MC4Rcombined with your thyroid biomarkerscan support a more informed conversation with your provider about whether GLP-1 therapy aligns with your individual physiology